Concepedia

177Lu-FAP-2286 Therapy in a Case of Recurrent Bladder Cancer With Multiple Metastatic Lesions

Linwei Li, Jian Yang, Dengsai Peng, Yu Zhang, Yue Chen

Clinical Nuclear Medicine · 2023 · 23 citations · 8 references

DOI

Concepts

Abstract

ABSTRACT: We reported a 73-year-old man who was diagnosed with the recurrence of bladder tumor received 177 Lu-FAP-2286 treatment. Encouragingly, radiological remission and alleviation of his symptom were noted. In addition, the patient did not have any adverse effects.

References

8

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using <sup>177</sup>Lu-FAP-2286: First-in-Humans Results

Richard P. Baum, Christiane Schuchardt, Aviral Singh et al. · Journal of Nuclear Medicine · 2021 · 327 citations · Full text

, , +17

Metastatic Pattern of Bladder Cancer: Correlation With the Characteristics of the Primary Tumor

Atul B. Shinagare, Nikhil H. Ramaiya, Jyothi P. Jagannathan et al. · American Journal of Roentgenology · 2010 · 272 citations

, , +15

Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy

Dirk Zboralski, Aileen Hoehne, Anne Bredenbeck et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 254 citations · Full text

, , +17

Patterns of Metastasis in Muscle-Invasive Bladder Cancer (pT2–4): An Autopsy Study on 367 Patients

Andreas Wallmeroth, Urs Wagner, H. Moch et al. · Urologia Internationalis · 1999 · 158 citations

, , +12

FAP-Targeted Radionuclide Therapy of Advanced Radioiodine-Refractory Differentiated Thyroid Cancer With Multiple Cycles of 177Lu-FAPI-46

Hao Fu, Jingxiong Huang, Long Sun et al. · Clinical Nuclear Medicine · 2022 · 41 citations

, , +17